Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Analysis of prognostic factors

Cancer

Volumn 73, Issue 5, 1994, Pages 1341-1345

  Taniguchi, Kenji ^a   Nakata, Keisuke ^a   Kato, Yuji ^a   Sato, Yoshiaki ^a   Hamasaki, Keisuke ^a   Tsuruta, Shohtaro ^a   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

hepatocellular carcinoma; prognostic factor; transcatheter arterial embolization; tumor multiplicity; tumor size

Indexed keywords

DOXORUBICIN; ETHIODIZED OIL; GELATIN SPONGE; MITOMYCIN C;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR THROMBUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0028218403     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940301)73:5<1341::AID-CNCR2820730506>3.0.CO;2-U     Document Type: Article

References (30)

1. Hepatocellular carcinoma in the world epidemiologic questions
2. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan
3. A‐Fetoprotein: reevaluation in hepatology
4. Lectin‐reactive profiles of alpha‐fetoprotein characterizing hepatocellular carcinoma and related conditions
5. Early recognition of hepatocellular carcinoma by altered lectin‐reactive profiles of alpha‐fetoprotein
6. Lipiodol computed tomography for small hepatocellular carcinomas [editorial]
7. Treatment of small hepatocellular carcinomas
8. Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong
9. Transcatheter arterial embolization of hepatic neoplasms
10. Therapeutic embolization of the hepatic artery: a review of 75 procedures
11. Efficacy of transcatheter arterial embolization therapy for small hepatocellular carcinomas: comparison with other treatments
12. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases
13. Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors
14. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma
15. Prognostic factors of hepatocelluar carcinoma in the West: a multivariate analysis in 206 patients
16. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion
17. Liver Cancer Study Group of Japan. The general rules for clinical and pathological study of primary liver cancer
18. Nonparametic estimation from incomplete observations
19. A generalized Wilcoxon test for comparing arbitrarily singly‐censored samples
20. Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization
21. Hepatocellular carcinoma
22. Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product
23. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki prefecture, Japan
24. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma
25. Transcatheter arterial chemoembolization for hepatocellular carcinoma
26. Hepatic arterial injection of 131I‐labelled lipiodol. Part I: biodistribution study result results in patients with hepatocellular carcinoma and liver metastases
27. Hepatic arterial injection of 131I‐labelled lipiodol. Part II: preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases
28. Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma
29. Intraarterial infusion of 5‐fluoro‐2‐deoxyuridine C8 dissolved in a lymphographic agent in malignant liver tumors
30. Adoptive immunotherapy with lymphokine‐activated killer cell plus recombinant interleukin‐2 in patients with unresectable hepatocellular carcinoma